Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents
The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
Iron is an essential micronutrient for the growth and function of all cells. It is, therefore, an attractive target for chemotherapeutic compounds. Numerous studies in vitro and in vivo provide evidence that iron chelators may be effective antitumor agents. Lipophilic iron chelators that are readily cell permeable and can bind intracellular iron stores may selectively kill cancer cells without damaging normal cells. In this review we discuss the role of iron in cellular processes and how these processes differ between normal and neoplastic cells. We also review the effects on normal and cancer cell growth of several lipophilic iron chelators.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron chelators [1438,1462] are thus a doubly attractive component of anti-cancer therapeutics.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1438]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2×
“Ubiquitination of HIF-1α is regulated by hydroxylation of a proline residue by the enzyme HIF-1α prolylhydroxylase (HIF-PH).[53] This hydroxylation requires both iron and oxygen as cofactors.”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“[53] This hydroxylation requires both iron and oxygen as cofactors.[53,54] Removal of iron by chelation prevents the hydroxylation and ubiquitination of HIF-1α, resulting in HIF-1 activation and the transcription of downstream target genes.”
BackgroundProduction of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520
(1999) · PubMed · Cited by 2,204
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Persistent oxidative stress in cancer
Toyokuni, S., Okamoto, K., Yodoi, J., & Hiai, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01368-b · Cited by 1,219
Research works printed but not linked: 14
- McCord J. M, 1998, Semin. Hematol., 35, 5
- Szatrowski T. P., 1991, Cancer Res., 51, 794
- Chaston T. B., 2003, Clin. Cancer Res., 9, 402
- Tomoyasu S., 1993, Anticancer Res., 13, 407
- Zhong H., 1999, Cancer Res., 59, 5830
- Becton D. L., 1989, Cancer Res., 49, 4809
- Brodie C., 1993, Cancer Res., 53, 3968
- Jiang X. P., 2002, Anticancer Res., 22, 2685
- Selig R. A., 1998, Cancer Res., 58, 473
- Donfrancesco A., 1990, Cancer Res., 50, 4929
- Howland M. A, 1996, Clin. Toxicol., 34, 491
- Kicic A., 2001, Anti-Cancer Drug Des., 16, 195
- Chong T. W., 2002, Cancer Res., 62, 6924
- Monks A., 1997, Anticancer Drug Des, 12, 533
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Lovejoy, D. B., Jansson, P. J., Brunk, U. T., Wong, J., Ponka, P., & Richardson, D. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1218 · Cited by 308
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
Richardson, D. R., Kalinowski, D. S., Lau, S., Jansson, P. J., & Lovejoy, D. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.003 · Cited by 258
Synthetic and natural iron chelators: Therapeutic potential and clinical use
Hatcher, H. C., Singh, R. N., Torti, F. M., & Torti, S. V. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.121 · Cited by 242
Potential involvement of iron in the pathogenesis of peritoneal endometriosis
Defrere, S., Lousse, J. C., Gonzalez-Ramos, R., Colette, S., Donnez, J., & Van Langendonckt, A. (2008) · Molecular Human Reproduction · doi:10.1093/molehr/gan033 · Cited by 204
Metadata
- Authors
- Pahl, P. M. B., & Horwitz, L. D.
- Affiliations
- University of Colorado Health (US)
- University of Colorado Denver (US)
- ORCID
- Horwitz, Lawrence D.
- Venue
- Cancer Investigation
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 23
- Issue
- 8
- Pages
- 683-691
- ISSN
- 0735-7907 (ISSN-L)
- 1532-4192
- OpenAlex
- W2164347232
- Cited by
- 40
- References
- 112
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 6 · 2013: 2 · 2012: 5
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 55291, R01HL055291)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- iron chelators, cancer chemotherapy, iron metabolism, selective cytotoxicity, cancer cell growth
- MeSH terms
- Animals, Antineoplastic Agents, Cell Membrane Permeability, Humans, Iron, Iron Chelating Agents, Neoplasms, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents. https://app.cochat.ai/papers/10.1080/07357900500359976
- The paper
- Pahl, P. M. B., & Horwitz, L. D. (2005). Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents. Cancer Investigation. https://doi.org/10.1080/07357900500359976
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.